Yekeduz, E. Et Al. 2022. Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. FUTURE ONCOLOGY , vol.18 , 413-416.

Yekeduz, E., UTKAN, G., & ÜRÜN, Y., (2022). Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. FUTURE ONCOLOGY , vol.18, 413-416.

Yekeduz, EMRE, GÜNGÖR UTKAN, And YÜKSEL ÜRÜN. "Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors," FUTURE ONCOLOGY , vol.18, 413-416, 2022

Yekeduz, EMRE Et Al. "Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors." FUTURE ONCOLOGY , vol.18, pp.413-416, 2022

Yekeduz, E. UTKAN, G. And ÜRÜN, Y. (2022) . "Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors." FUTURE ONCOLOGY , vol.18, pp.413-416.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors}, journal={FUTURE ONCOLOGY}, year=2022, pages={413-416} }